If we are sure of one thing a year after the beginning of the pandemic, it is that COVID-19 has rapidly accelerated the implementation of different technology models that, in certain clinical specialties, had been in development for years, but were only being implemented slowly. That is the situation of Teledermatology (TD), which has played a greater role during the pandemic, in spite of not being new.
Today is World Cancer Day, a day that is dedicated to commemorating the fight against this significant disease that, as of today, continues affecting millions of people in the world every year. In Spain, it is estimated that the number of new cancer cases in 2021 will grow to 276,239, and to approximately 30 million around the world in 2040.
During the COVID-19 pandemic we have seen how specialized hospital units and services have been obligated to reorganize themselves in order to provide continuity in healthcare, while at the same time trying to avoid new infections among their patients. Providers began to integrate phone calls into their approach to carrying out patient monitoring, as well as using different technological tools.
The term “precision medicine” has become more prominent because of the advances in healthcare and technology that are enabling a greater understanding of the predisposition to certain diseases and/or ways to prevent them. These advances have allowed for the development of therapies that are directed toward specific patients with more specific disease profiles.
The team at Persei vivarium would like to wish you a Merry Christmas and a healthy 2021.
This year, more than ever, we hope you can enjoy the holidays safely, and that the coming year arrives full of health and new and prosperous beginnings.
Our best wishes for you and for your families and friends.
EPICOS, the clinical trial for prevention of COVID-19 in healthcare workers, developed with Persei vivarium technology, is expanding to Latin America
EPICOS, the clinical trial for prevention of coronavirus infection in healthcare workers, promoted by the Spanish Ministry of Health and managed by the technology and teams at Persei vivarium and Effice Research, has been expanded to Latin America, where they intend to enroll 2,080 more professionals.